Deciphering the pathogenesis of coagulation dysfunction in leukemia

Leukemia Research

Volumn 20, Issue 1, 1996, Pages 13-16

  Tallman, M S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCOAGULANT; RETINOIC ACID; THROMBOPLASTIN;

ACUTE MYELOBLASTIC LEUKEMIA; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; FIBRINOLYSIS; HUMAN; MYELOPOIESIS; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTE; SHORT SURVEY;

EID: 0030022045     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00109-3     Document Type: Note

References (52)

1. A. Trousseau Phlegmasia alba dolens New Sydenham Soc. 3 1865 Cliniqua Mediacal de Hotel-Dieu de Paris London 695
2. G.H. Sack Jr J. Levin W. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathologic and therapeutic features Medicine 56 1977 1
3. R.B. Weiss D.C. Tormey J.F. Holland V.E. Weinberg Venous thrombosis during multimodal treatment of primary breast carcinoma Cancer Treat. Rep. 65 1981 677
4. J. Lisiewicz Mechanisms of hemorrhage in leukemias Semin. Thromb. Hemost. 4 1978 241
5. J.J. Rand W.D. Moloney H.S. Sise Coagulation defects in acute promyelocytic leukemia Arch. Int. Med. 123 1969 39
6. P. Brackman J. Snyder E.S. Henderson T. Astrep Blood coagulation and fibrinolysis in acute leukemia Br. J. Haematol. 18 1970 135
7. R.A. Leavey S.B. Kahn I. Brodsky Disseminated intravascular coagulation—a complication of chemotherapy in acute myelomonocytic leukemia Cancer 26 1970 142
8. L. Talarico L.R. Weintraub Leukocytic fibrinolysis in myelomonocytic leukemia Cancer 39 1977 1618
9. Y. Furukawa M. Ohta Y. Miura M. Saito Interleukin 1 production by monocytic leukemia cells and its possible role in coagulation abnormalities Leukemia Res. 15 1991 1133
10. H.R. Gralnick J. Bagley E. Abrell Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia Am. J. Med. 52 1972 167
11. M.E. Jones A. Saleem Acute promyelocyte leukemia: a review of the literature Am. J. Med. 65 1978 673
12. C. Cordonnier J.P. Vernant B. Brun Acute promyelocytic leukemia in 57 previously untreated patients Cancer 55 1985 18
13. M.S. Tallman H.C. Kwaan Reassessing the coagulopathy in acute promyelocytic leukemia Blood 79 1992 542
14. J. Kadish K. Wenc H.F. Dvorak Tissue factor activity of normal neoplastic cells: quantitation and species specificity J. natn. Cancer Inst. 70 1983 551
15. H.F. Dvorak S.C. Quay N.S. Oranstein Tumor shedding and coagulation Science 212 1981 923
16. M. Kinjo K. Oak S. Naito Thromboplastic and fibrinolytic activities of cultured human cancer cell lines Br. J. Cancer 39 1979 15
17. L.R. Zacharski A.R. Schned G.D. Sorenson Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung Cancer Res. 43 1983 3963
18. A. Guarini L. Gugliotta C. Timoncini Procoagulant cellular activity in disseminated intravascular coagulation in acute nonlymphoid leukaemia Scand. J. Haematol. 34 1985 152
19. F.R. Rickles R.L. Edwards Activation of blood coagulation in cancer: Trousseau's syndrome revisited Blood 62 1983 14
20. J. Bernard M. Weil M. Boiron C. Jacquillat G. Flandrin M. Gemon Acute promyelocytic leukemia: results of treatment of daunorubicin Blood 41 1973 489
21. A.J. Collins C.D. Bloomfield B.A. Peterson R.W. McKenna R. Edson Acute promyelocytic leukemia: management of the coagulopathy during daunorubicin-prednisone remission induction Arch. Int. Med. 138 1978 1677
22. M.A. Goldberg D. Ginsburg R.J. Mayer R.M. Stone M. Maguire D.S. Rosenthal J.H. Antin Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Blood 69 1987 187
23. I. Cunningham T.S. Gee L.M. Reich S.J. Kempin A.N. Naval B.D. Clarkson Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital Blood 73 1989 116
24. S. Castaigne C. Chomienne M.T. Daniel All- trans -retinoic acid as differentiation therapy for acute promyelocytic leukemia. I. Clinical results Blood 76 1990 1704
25. J.R.P. Warrell S.R. Frankel W.H. Miller Differentiation therapy of acute promyelocytic leukemia with tretinoin (all- trans -retinoic acid) N. Engl. J. Med. 324 1991 1385
26. Z.-X. Chen Y.-Q. Xue R. Zhang A clinical and experimental study on all- trans -retinoic acid-treated acute promyelocytic leukemia patients Blood 78 1991 1413
27. P. Fenaux S. Castaigne H. Dombret All- trans -retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases Blood 80 1992 2176
28. P. Fenaux M.C. Le Deley S. Castaigne Effect of all- trans -retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial Blood 82 1993 3241
29. G.A. Hair S. Padula R. Zeff Tissue factor expression in human leukemic cells Leukemia Res. 20 1996 1
30. W.T. Dalton M.J. Ahearn K.B. McCredie E.J. Freireich S.A. Stass J.M. Trujillo HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3 Blood 71 1988 242
31. M. Lanotte V. Martin-Thouvenin S. Najman P. Ballerini F. Valens R. Bergen NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3) Blood 77 1991 1080
32. S.G. Gordon J.J. Franks B. Lewis Cancer procoagulant A: a factor X-activating procoagulant from malignant tissue Thromb. Res. 6 1975 127
33. S.G. Gordon U. Hasiba M.A. Poole B.A. Cross A. Falanga Cysteine proteinase procoagulant from amnion-chorion Blood 66 1985 1261
34. M.B. Donati C. Gambacorti-Passerin B. Casali A. Falanga P. Vannotti G. Fossati N. Semeraro S.G. Gordon Cancer procoagulant in human tumor cells: evidence from melanoma patients Cancer Res. 46 1986 6471
35. A. Falanga M.G. Alessio M.B. Donati T. Barbui A new procoagulant in acute leukemia Blood 71 1988 870
36. M.B. Donati A. Falanga R. Consonni Cancer procoagulant in acute nonlymphoid leukemia: relationship of enzyme detection to disease activity Thromb. Haem. 64 1990 11
37. M.P. Bevilacqua J.S. Pober G.R. Majeau Interleukin 1 (IL-1) induces biosynthesis and cell surface expression activity of procoagulant activity in human vascular endothelial cells J. Expl Med. 160 1984 618
38. P.P. Nawroth D. Handley C.T. Esmon D.M. Stern Interleukin-1 induces cell surface anticoagulant activity Proc. natn. Acad. Sci. USA 83 1986 340
39. P.P. Nawroth D.M. Stern Modulation of endothelial cell hemostatic properties by tumor necrosis factor J. Expl Med. 163 1986 740
40. M. Bevilacqua J. Prober G. Magear Recombinant human tissue necrosis factor induces procoagulant activity in cultured human vascular endothelium. Characterization and comparison with interleukin-1 Proc. natn. Acad. Sci. USA 83 1986 4533
41. M. Clauss M. Gerlach H. Gerlach Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration J. Expl Med. 172 1990 1535
42. H. Dombret M.-L. Scrobohaci M.-T. Daniel In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all- trans -retinoic acid (ATRA) therapy Leukemia 9 1995 19
43. L.H. Kahle G. Avvisati R.J. Lampling Turnover of alpha-2 antiplasmin in patients with acute promyelocytic leukemia Scand. J. Clin. Lab. Med. 45 1985 75
44. B.S. Schwartz E.C. Williams M.G. Conlan D.F. Mosher Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency Ann. Int. Med. 105 1986 873
45. Y. Sakata T. Murakami A. Noro The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia Blood 77 1991 1949
46. K.S. Chang G. Wang E.J. Freireich Specific expression of the annexin VIII gene in acute promyelocytic leukemia Blood 79 1992 1802
47. 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids Proc. natn. Acad. Sci. USA 77 1980 2533
48. H. Ishii S. Horie K. Kizaki M. Kazama Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor Blood 80 1992 2556
49. F.R. Rickles G. Hair M. Schmeizl All- trans -retinoic acid (ATRA) inhibits the expression of tissue factor in human progranulocytic leukemia cells Thromb. Haem. 69 1993 573 (abstr.)
50. T. Koyama S. Hirosawa N. Kawamata S. Tohda N. Aoki All- trans -retinoic acid upregulates and down-regulates tissue factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemia cells Blood 84 1994 3001
51. H. Dombret M.L. Scrobohari P. Ghorra Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all- trans -retinoic acid treatment Leukemia 7 1993 2
52. Y. Sakata T. Murakami A. Noro K. Mori M. Matsuda The specific activity of plasminogen activator inhibiter-1 in disseminated intravascular coagulation with acute promyelocytic leukemia Blood 77 1991 1949